NM_001377299.1:c.*114A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001377299.1(NDUFS2):​c.*114A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.186 in 900,098 control chromosomes in the GnomAD database, including 15,774 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.14 ( 1776 hom., cov: 30)
Exomes 𝑓: 0.19 ( 13998 hom. )

Consequence

NDUFS2
NM_001377299.1 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.836

Publications

39 publications found
Variant links:
Genes affected
NDUFS2 (HGNC:7708): (NADH:ubiquinone oxidoreductase core subunit S2) The protein encoded by this gene is a core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (complex I). Mammalian mitochondrial complex I is composed of at least 43 different subunits, 7 of which are encoded by the mitochondrial genome, and the rest are the products of nuclear genes. The iron-sulfur protein fraction of complex I is made up of 7 subunits, including this gene product. Complex I catalyzes the NADH oxidation with concomitant ubiquinone reduction and proton ejection out of the mitochondria. Mutations in this gene are associated with mitochondrial complex I deficiency. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009]
NDUFS2 Gene-Disease associations (from GenCC):
  • Leigh syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • mitochondrial complex I deficiency, nuclear type 6
    Inheritance: AR, Unknown Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • Leigh syndrome with cardiomyopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Leigh syndrome with leukodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • mitochondrial complex I deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Leber hereditary optic neuropathy
    Inheritance: Mitochondrial Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 1-161214307-A-G is Benign according to our data. Variant chr1-161214307-A-G is described in ClinVar as Benign. ClinVar VariationId is 293289.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.288 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NDUFS2NM_001377299.1 linkc.*114A>G 3_prime_UTR_variant Exon 14 of 14 ENST00000676972.1 NP_001364228.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NDUFS2ENST00000676972.1 linkc.*114A>G 3_prime_UTR_variant Exon 14 of 14 NM_001377299.1 ENSP00000503117.1 O75306-1

Frequencies

GnomAD3 genomes
AF:
0.142
AC:
20411
AN:
143926
Hom.:
1776
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0443
Gnomad AMI
AF:
0.120
Gnomad AMR
AF:
0.192
Gnomad ASJ
AF:
0.142
Gnomad EAS
AF:
0.301
Gnomad SAS
AF:
0.295
Gnomad FIN
AF:
0.209
Gnomad MID
AF:
0.158
Gnomad NFE
AF:
0.156
Gnomad OTH
AF:
0.159
GnomAD4 exome
AF:
0.194
AC:
146600
AN:
756068
Hom.:
13998
Cov.:
11
AF XY:
0.198
AC XY:
77343
AN XY:
390656
show subpopulations
African (AFR)
AF:
0.0476
AC:
894
AN:
18798
American (AMR)
AF:
0.305
AC:
9596
AN:
31458
Ashkenazi Jewish (ASJ)
AF:
0.151
AC:
3016
AN:
19956
East Asian (EAS)
AF:
0.336
AC:
10118
AN:
30158
South Asian (SAS)
AF:
0.304
AC:
18705
AN:
61588
European-Finnish (FIN)
AF:
0.209
AC:
9270
AN:
44402
Middle Eastern (MID)
AF:
0.197
AC:
622
AN:
3160
European-Non Finnish (NFE)
AF:
0.172
AC:
87803
AN:
511142
Other (OTH)
AF:
0.186
AC:
6576
AN:
35406
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
6123
12246
18368
24491
30614
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2442
4884
7326
9768
12210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.142
AC:
20419
AN:
144030
Hom.:
1776
Cov.:
30
AF XY:
0.149
AC XY:
10427
AN XY:
70138
show subpopulations
African (AFR)
AF:
0.0442
AC:
1711
AN:
38684
American (AMR)
AF:
0.193
AC:
2782
AN:
14430
Ashkenazi Jewish (ASJ)
AF:
0.142
AC:
487
AN:
3424
East Asian (EAS)
AF:
0.301
AC:
1425
AN:
4732
South Asian (SAS)
AF:
0.295
AC:
1338
AN:
4534
European-Finnish (FIN)
AF:
0.209
AC:
2062
AN:
9858
Middle Eastern (MID)
AF:
0.174
AC:
49
AN:
282
European-Non Finnish (NFE)
AF:
0.156
AC:
10143
AN:
65216
Other (OTH)
AF:
0.159
AC:
317
AN:
1996
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
847
1694
2540
3387
4234
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
236
472
708
944
1180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.150
Hom.:
4103
Bravo
AF:
0.133
Asia WGS
AF:
0.282
AC:
979
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mitochondrial complex I deficiency, nuclear type 6 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mitochondrial complex I deficiency, nuclear type 1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.99
DANN
Benign
0.50
PhyloP100
-0.84
RBP_binding_hub_radar
1.1
RBP_regulation_power_radar
2.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1136224; hg19: chr1-161184097; COSMIC: COSV107324287; COSMIC: COSV107324287; API